21 CFR Part 11, Annex 11 & HIPAA Compliance

Data integrity starts with attribution. On GxP Linux, that means provable identity control.

Shared admin accounts, unattributed sudo, and orphaned access on LIMS, MES, and PHI systems are the audit-trail deficiencies regulators cite first. Our pilot ties privileged actions to the originating person and produces evidence aligned to 21 CFR Part 11, EU Annex 11, and the HIPAA Security Rule.

Why Pharma & Healthcare Makes Linux Identity Visible

  • Shared and admin accounts on GxP Linux systems are among the most-cited audit-trail deficiencies in FDA warning letters — they break attribution and least privilege, the foundation of ALCOA+ data integrity.
  • FDA 21 CFR Part 11 §11.10(e) requires computer-generated, time-stamped, tamper-evident audit trails that no administrator can silently alter. LinuxGuard provides tamper-evident audit logging and ties every sudo escalation to the originating human — a genuine product capability, not a claim of validation.
  • Privileged access to validated systems — sudo on LIMS and MES with no continuous evidence — puts the validation state at risk. LinuxGuard detects privilege and configuration drift on a 60-second interval, so change to a validated system is visible rather than silent.
  • Leaver access on PHI systems is a reportable gap under the HIPAA Security Rule access-control standard. The pilot surfaces orphaned accounts and the privileges they still hold across systems handling protected health information.
  • Non-human identities — service and system accounts on regulated Linux — now outnumber humans by roughly 109 to 1 (Palo Alto Networks, 2026 Identity Security Landscape), and they rarely appear in a QA-led access review despite holding real privilege on validated systems.

How the Founding Pilot Addresses 21 CFR Part 11, Annex 11 & HIPAA Requirements

Every pilot finding is mapped to specific 21 CFR Part 11, Annex 11 & HIPAA controls, providing direct compliance evidence for your regulatory submissions.

Scroll horizontally to see all columns →

Article / RequirementWhat It MandatesHow the Founding Pilot Covers It
21 CFR Part 11 §11.10(d)Limit system access to authorized individualsInventory of who holds access and privilege on GxP Linux hosts, with least-privilege gaps flagged
21 CFR Part 11 §11.10(e)Secure, computer-generated, time-stamped audit trailsAssessment of audit-trail coverage and tamper-evidence for privileged actions, tying sudo escalation to the originating person
21 CFR Part 11 §11.10(g)Authority checks — only authorized individuals use the systemDetection of shared accounts and unattributed access that undermine authority checks on validated systems
EU GMP Annex 11 (ALCOA+)Access control and data integrity for computerised systemsAttribution and access-control evidence supporting ALCOA+ data-integrity expectations for GxP Linux systems
HIPAA Security Rule §164.312(a)/(b)Access control and audit controls for PHI systemsUnique-user and audit-trail assessment on Linux systems handling protected health information, flagging orphaned access

What You Get

  • Identity & Privilege Inventory — Every user, group, sudo rule, SSH key, and service account across your Linux estate, showing who can do what
  • Risk-Scored Findings Report — Prioritized findings based on real exploit patterns, highlighting the privilege paths attackers would use first
  • Compliance Evidence Package — Identity governance gaps mapped to 21 CFR Part 11, EU GMP Annex 11, and the HIPAA Security Rule with remediation guidance
  • Prioritized Remediation Plan — Phased plan to reduce privilege drift and move toward least-privilege, with a zero trust alignment overlay where applicable
  • Board-Ready Executive Summary — Executive summary for boards and a technical deep-dive for your security team

How the Founding Pilot Works

The Founding Pilot runs in four phases over 60 days — discovery and scoping, identity and privilege mapping with lightweight read-only collectors, a security and compliance assessment that maps findings to 21 CFR Part 11, EU Annex 11, and the HIPAA Security Rule controls, and reporting with a prioritised least-privilege remediation roadmap. See the Founding Pilot for the full four-phase process, timeline, and deliverables.

Frequently Asked Questions

Does the pilot validate our systems or certify them against Part 11?
No — and that distinction matters in a regulated environment. Validation is your responsibility for your systems and intended use; LinuxGuard is not a validation service and does not certify systems. What LinuxGuard does is support the Part 11 and Annex 11 control objectives — attribution of privileged actions, least privilege, and tamper-evident audit trails — and produce the evidence your QA and audit functions need to demonstrate them.
How does LinuxGuard support attribution and audit-trail integrity?
21 CFR Part 11 §11.10(e) calls for tamper-evident, time-stamped audit trails, and ALCOA+ data integrity depends on attributing every action to a named person. LinuxGuard ties each sudo escalation on a Linux host back to the originating human and provides tamper-evident audit logging of privileged actions — so shared-account and unattributed-access deficiencies, the ones most cited in FDA warning letters, become visible and evidenced.
What is the status of the EU Annex 11 revision?
A major revision to EU GMP Annex 11 has been through public consultation, with the final text expected to adopt over the following period alongside a transition. Because the revised requirements are not yet fully in force, we scope pilots against the current Annex 11 expectations and the direction of the revision — access control, cybersecurity, and ALCOA+ data integrity — rather than presenting draft requirements as settled law. We confirm the applicable status at scoping.
Does this cover the HIPAA changes we have been hearing about?
The HIPAA Security Rule access-control and audit-control standards (§164.312) apply today, and the pilot maps to those. Separately, a Notice of Proposed Rulemaking published in January 2025 would, if finalized, make measures such as MFA and audit logging mandatory and tighten access-termination timelines — but that remains a proposal, not current law. We treat it as proposed and help you prepare for the direction of travel without overstating the requirement.
How long does the pharma & healthcare pilot take?
The pilot is a fixed-scope engagement covering scoping and data collection, analysis mapping findings to 21 CFR Part 11, EU Annex 11, and HIPAA Security Rule controls, and delivery of the evidence package, executive summary, and remediation roadmap with a readout for your team. See the Founding Pilot page for the full timeline.

Ready to demonstrate GxP data-integrity evidence?

Request your pharma & healthcare pilot and receive access-control and attribution evidence aligned to 21 CFR Part 11, EU Annex 11, and the HIPAA Security Rule.